Department of Health and Social Care written question – answered at on 21 January 2019.
To ask Her Majesty's Government whether the “Serious Shortage Protocol”, as set out in the document Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal, published on 4 January, will be applied to patients involved in clinical trials; and what assessment they have made of the risk of jeopardising the conduct of clinical trials and the data collected by the application of the protocol to such trials.
The provisions exempt retail pharmacies from dispensing against a prescription when a serious shortage protocol is in place. We do not envisage it would apply to medicines not supplied on prescription, including those supplied as part of a clinical trial. Therefore, no such assessment has been made.
Yes1 person thinks so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.